Amarin Corp Plc (AMRN)

[ziploc_1]

Study...QUOTE..." a study has never been funded looking at the difference of CVD differences between gV and V users."

The FDA has recently changed its mind after demanding an event study from Amarin for CVD ....It now seems willing to approve drugs on lab studies...A lab study showing that the EPA in gV was oxidized...together with an understanding that oxidized EPA is inferior to unoxidized EPA should be sufficient to determine the inferiority of gV.